Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DS5

X-ray structure of the MK5890 Fab - CD27 antibody-antigen complex

Summary for 8DS5
Entry DOI10.2210/pdb8ds5/pdb
DescriptorCD27 antigen, MK-5890 Fab light chain, MK-5890 Fab heavy chain, ... (6 entities in total)
Functional Keywordscomplex, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight66905.52
Authors
Fischmann, T.O. (deposition date: 2022-07-21, release date: 2022-09-28, Last modification date: 2024-10-30)
Primary citationGuelen, L.,Fischmann, T.O.,Wong, J.,Mauze, S.,Guadagnoli, M.,Babala, N.,Wagenaars, J.,Juan, V.,Rosen, D.,Prosise, W.,Habraken, M.,Lodewijks, I.,Gu, D.,Stammen-Vogelzangs, J.,Yu, Y.,Baker, J.,Lutje Hulsik, D.,Driessen-Engels, L.,Malashock, D.,Kreijtz, J.,Bertens, A.,de Vries, E.,Bovens, A.,Bramer, A.,Zhang, Y.,Wnek, R.,Troth, S.,Chartash, E.,Dobrenkov, K.,Sadekova, S.,van Elsas, A.,Cheung, J.K.,Fayadat-Dilman, L.,Borst, J.,Beebe, A.M.,Van Eenennaam, H.
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy.
J Immunother Cancer, 10:-, 2022
Cited by
PubMed Abstract: Immune checkpoint inhibitors (ICI) have radically changed cancer therapy, but most patients with cancer are unresponsive or relapse after treatment. MK-5890 is a CD27 agonist antibody intended to complement ICI therapy. CD27 is a member of the tumor necrosis factor receptor superfamily that plays a critical role in promoting responses of T cells, B cells and NK cells.
PubMed: 36100308
DOI: 10.1136/jitc-2022-005049
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.926 Å)
Structure validation

239149

건을2025-07-23부터공개중

PDB statisticsPDBj update infoContact PDBjnumon